Kai Lee Yap

1.6k total citations
42 papers, 1.0k citations indexed

About

Kai Lee Yap is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kai Lee Yap has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in Kai Lee Yap's work include Genomics and Rare Diseases (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Epigenetics and DNA Methylation (4 papers). Kai Lee Yap is often cited by papers focused on Genomics and Rare Diseases (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Epigenetics and DNA Methylation (4 papers). Kai Lee Yap collaborates with scholars based in United States, Japan and China. Kai Lee Yap's co-authors include Yusuke Nakamura, Kazuma Kiyotani, Peter H. O’Donnell, Tatjana Antic, Xin Liu, J. C. Thenmozhiyal, Paul C. Ho, Natini Jinawath, I.-M. Shih and Noura J. Choudhury and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Kai Lee Yap

39 papers receiving 1.0k citations

Peers

Kai Lee Yap
Comparison fields: 5 of 88
  • Molecular Biology 481
  • Oncology 306
  • Cancer Research 203
  • Surgery 195
  • Immunology 176
Replace Yun Hee Kang with:
Yun Hee Kang South Korea
Gregory Dyson United States
Xiangyuan Liu China
Zhijie Xiao China
Panagiotis Sarantis Greece
Sarah Sarkar United States
Yanyan Shen China
Sven A. Lang Germany
Yoshifumi Nakayama Japan
Gopal Gopisetty India
Yun Hee Kang South Korea View profile →
Citations per field, relative to Kai Lee Yap
Kai Lee Yap · 1×
Citations per year, relative to Kai Lee Yap
Kai Lee Yap · 1×

Countries citing papers authored by Kai Lee Yap

Since Specialization
Citations

This map shows the geographic impact of Kai Lee Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lee Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lee Yap more than expected).

Fields of papers citing papers by Kai Lee Yap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Lee Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lee Yap. The network helps show where Kai Lee Yap may publish in the future.

Co-authorship network of co-authors of Kai Lee Yap

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Lee Yap. A scholar is included among the top collaborators of Kai Lee Yap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Lee Yap. Kai Lee Yap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 2
4 5
5 0
6 4
7 12
8 9
9 4
10 16
11 18
12 10
13 45
14 66
15 94
16 64
17 17
18 33
19 29
20 8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026